Metabolic Regulation of Toll-like Receptor Agonist Therapy in Leukemia
Metabolic Regulation of Toll-like Receptor Agonist Therapy in Leukemia
批准号:
170526
负责人:
Spaner David E
金额:
$27.73万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-09-01 至 2011-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Chemotherapy does not cure most cancers. However, the results with chemotherapy may be improved with treatments that increase the ability of the immune system to kill cancer cells (or immunotherapy). We have found that a new agent (called S28690), which
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the role of type 1 interferon in resistance to cancer immunotherapy
-
批准号:364090
-
项目类别:Operating Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Spaner David E
-
依托单位:
Targeting Interferon-beta in leukemia immunotherapy
-
批准号:354690
-
项目类别:Operating Grants
-
资助金额:$33.44万
-
财政年份:2016
-
负责人:Spaner David E
-
依托单位:
Improving Glucocorticoid Therapy in Leukemia
-
批准号:278420
-
项目类别:Operating Grants
-
资助金额:$27.47万
-
财政年份:2013
-
负责人:Spaner David E
-
依托单位:
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
-
批准号:81673007
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2016
-
负责人:金时
-
依托单位: